机构:[1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.北京大学深圳医院深圳市康宁医院深圳市南山区人民医院深圳医学信息中心中国医学科学院肿瘤医院深圳医院[3]Department of Breast Surgery, Clinical Research Center for Breast, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[4]Suzhou Industrial Park Monash Research Institute of Science and Technology, Suzhou, China.[5]The School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
China National Key R&D (or Research and
Development) Program, Grant/Award Numbers:
2020AAA0105000, 2020AAA0105004; National
Natural Science Foundation of China,
Grant/Award Numbers: 82173328, 81872160,
82072940, 82103047, 82102887; CAMS
Innovation Fund for Medical Sciences (CIFMS),Grant/Award Numbers: 2021‐I2M‐C&T‐A‐012,
2021‐I2M‐C&T‐B‐044, 2022‐I2M‐C&T‐B‐087;
Non‐profit Central Research Institute Fund of
Chinese Academy of Medical Sciences,
Grant/Award Number: 2022‐JKCS‐04; Young Elite
Scientist Sponsorship Program By BAST,
Grant/Award Numbers: BYESS2022066,
BYESS2023049; Beijing Association for Science
and Technology's “Golden‐Bridge Seed Funding
Program, Grant/Award Number: ZZ22027; Beijing
Hope Run Special Fund of Cancer Foundation of
China, Grant/Award Numbers: LC2020L01,
LC2019L07, LC2022A19; Chinese Young Breast
Experts Research Project, Grant/Award Number:
CYBER‐2021‐005; XianSheng Clinical Research
Special Fund of China International Medical
Foundation, Grant/Award Number: Z‐2014‐06‐
2103; Beijing Xisike Clinical Oncology Research
Foundation, Grant/Award Numbers:
Y‐Young2021‐0017, Y‐NESTLE2022QN‐0018
第一作者机构:[1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.[2]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.[*1]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.[*2]Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China.
推荐引用方式(GB/T 7714):
Kong Xiangyi,Song Jiarui,Gao Peng,et al.Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy[J].MEDICINAL RESEARCH REVIEWS.2024,44(2):606-631.doi:10.1002/med.21998.
APA:
Kong Xiangyi,Song Jiarui,Gao Peng,Gao Ran,Zhang Lin...&Wang Jing.(2024).Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy.MEDICINAL RESEARCH REVIEWS,44,(2)
MLA:
Kong Xiangyi,et al."Revolutionizing the battle against locally advanced breast cancer: A comprehensive insight into neoadjuvant radiotherapy".MEDICINAL RESEARCH REVIEWS 44..2(2024):606-631